Home Biocure Technology

Biocure Technology

In operation
IPO
Cell Therapy Developer
Basic
Enterprise Profile

Basic Information

Biocure Technology Inc. is a biopharmaceutical company composed of top scientists, specializing in the development and commercialization of CAR T-cell therapies for chronic lymphocytic leukemia and solid tumor cancers. Additionally, the company is developing biosimilar technologies for cancer treatment. CAR T-cell cancer therapy is one of the most innovative cancer treatment methods currently on the market and has garnered widespread attention globally.
Biocure Technology Inc.
Vancouver,BritishColumbia,Canada
15~50 people
January 01, 2007
info@biocuretech.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Cell Technology
Concept
Therapeutic Products Leukemia
Application Scenarios
Generic Drug Innovative Drugs